Characterization of driver mutations in Chinese non-small cell lung cancer patients using a novel targeted sequencing panel

por Zhao, Jing, Wu, Yang, Chen, Min-Jiang, Xu, Yan, Zhong, Wei, Wang, Meng-Zhao
Publicado 2022

Evaluation of safety and efficacy of gefitinib ('iressa', zd1839) as monotherapy in a series of Chinese patients with advanced non-small-cell lung cancer: experience from a compass...

por Mu, Xin-Lin, Li, Long-Yun, Zhang, Xiao-Tong, Wang, Shu-Lan, Wang, Meng-Zhao
Publicado 2004

Small-Cell Lung Cancer Transformation in Patients With Pulmonary Adenocarcinoma: A Case Report and Review of Literature

por Jiang, Shi-Yu, Zhao, Jing, Wang, Meng-Zhao, Huo, Zhen, Zhang, Jing, Zhong, Wei, Xu, Yan
Publicado 2016

Case Report: A Programmed Cell Death-1 Inhibitor-Related Abdominal Fibroinflammatory Reaction Affecting Multiple Organs in A Non-Small-Cell Lung Cancer Patient

por Chen, An-Tian, Shi, Yue-Quan, Tan, Bei, Zhu, Liang, Luo, Ya-Ping, Zhong, Wei, Wang, Meng-Zhao, Xu, Yan
Publicado 2022

Gut microbiota shed new light on the management of immune‐related adverse events

por Tan, Bei, Liu, Yun‐xin, Tang, Hao, Chen, Dan, Xu, Yan, Chen, Min‐jiang, Li, Yue, Wang, Meng‐zhao, Qian, Jia‐ming
Publicado 2022

Clinical‐radiological characteristics and intestinal microbiota in patients with pancreatic immune‐related adverse events

por Tan, Bei, Chen, Min‐jiang, Guo, Qi, Tang, Hao, Li, Yue, Jia, Xin‐miao, Xu, Yan, Zhu, Liang, Wang, Meng‐zhao, Qian, Jia‐ming
Publicado 2021

A double-blind, randomized phase II study of dicycloplatin plus paclitaxel versus carboplatin plus paclitaxel as first-line therapy for patients with advanced non-small-cell lung c...

por Liu, Ke-Jun, Guan, Zhong-Zhen, Liang, Ying, Yang, Xu-Qing, Peng, Jin, Huang, He, Shao, Qing-Xiang, Wang, Meng-Zhao, Zhu, Yun-Zhong, Wu, Chang-Ping, Wang, Shao-Bin, Xiong, Jian-Ping, Bai, Yu-Xian, Yu, Shi-Ying, Zhang, Yang, Hu, Xiao-Hua, Feng, Ji-Feng, Wu, Shi-Xiu, Jiao, Shun-Chang, Zhou, Cai-Cun, Wang, Jie, Wu, Hai-Ying
Publicado 2014

Clinical recommendations for perioperative immunotherapy‐induced adverse events in patients with non‐small cell lung cancer

por Ni, Jun, Huang, Miao, Zhang, Li, Wu, Nan, Bai, Chun‐Xue, Chen, Liang‐An, Liang, Jun, Liu, Qian, Wang, Jie, Wu, Yi‐Long, Zhang, Feng‐Chun, Zhang, Shu‐Yang, Chen, Chun, Chen, Jun, Fang, Wen‐Tao, Gao, Shu‐Geng, Hu, Jian, Jiang, Tao, Li, Shan‐Qing, Li, He‐Cheng, Liao, Yong‐De, Liu, Yang, Liu, De‐Ruo, Liu, Hong‐Xu, Liu, Jian‐Yang, Liu, Lun‐Xu, Wang, Meng‐Zhao, Wang, Chang‐Li, Yang, Fan, Yang, Yue, Zhang, Lan‐Jun, Zhi, Xiu‐Yi, Zhong, Wen‐Zhao, Guan, Yu‐Zhou, Guo, Xiao‐Xiao, He, Chun‐Xia, Li, Shao‐Lei, Li, Yue, Liang, Nai‐Xin, Lu, Fang‐Liang, Lv, Chao, Lv, Wei, Si, Xiao‐Yan, Tan, Feng‐Wei, Wang, Han‐Ping, Wang, Jiang‐Shan, Yan, Shi, Yang, Hua‐Xia, Zhu, Hui‐Juan, Zhuang, Jun‐Ling, Zhuo, Ming‐Lei
Publicado 2021